Standard name |
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN |
Systematic name |
M14386 |
Brief description |
Genes down-regulated in A549GARS cells (lung cancer) resistant to the geldanamycin and 17-AAG [PubChem=5476289;6440175]. |
Full description or abstract |
Despite studies that show the antitumor activity of Hsp90 inhibitors, such as geldanamycin (GA) and its derivative 17-allylamino-demethoxygeldanamycin (17-AAG), recent reports indicate that these inhibitors lack significant single-agent clinical activity. Resistance to Hsp90 inhibitors has been previously linked to expression of P-glycoprotein (P-gp) and the multidrug resistant (MDR) phenotype. However, the stress response induced by GA treatment can also cause resistance to Hsp90-targeted therapy. Therefore, we chose to further investigate the relative importance of P-gp and the stress response in 17-AAG resistance. Colony-forming assays revealed that high expression of P-gp could increase the 17-AAG IC(50) 6-fold in cells transfected with P-gp compared with parent cells. A549 cells selected for resistance to GA overexpressed P-gp, but verapamil did not reverse the resistance. These cells also overexpressed Hsp27, and Hsp70 was induced with 17-AAG treatment. When the GA and 17-AAG resistant cells were transfected with Hsp27 and/or Hsp70 small interfering RNA (siRNA), the 17-AAG IC(50) decreased 10-fold compared with control transfected cells. Transfection with siRNA directed against Hsp27, Hsp70, or Hsp27 and Hsp70 also increased sensitivity to EC78, a purine scaffold-based Hsp90 inhibitor that is not a P-gp substrate. We conclude that P-gp may contribute, in part, to resistance to 17-AAG, but induction of stress response proteins, such as Hsp27 and Hsp70, by Hsp90-targeted therapy plays a larger role. Taken together, our results indicate that targeting of Hsp27 and Hsp70 should be exploited to increase the clinical efficacy of Hsp90-directed therapy. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 18794130 Authors: McCollum AK,TenEyck CJ,Stensgard B,Morlan BW,Ballman KV,Jenkins RB,Toft DO,Erlichman C |
Exact source |
Table 1S: Mean Difference (log2) < 0 |
Related gene sets |
(show 1 additional gene sets from the source publication)
(show 2 gene sets from the same authors)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Jessica Robertson (MSigDB Team) |
Source platform or identifier namespace |
AFFY_HG_U133 |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 7 genes
|
Gene families ? |
Categorize these
7 genes by gene family
|
Show members |
(show 7 source identifiers mapped to 7 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
203238_s_at |
4854 |
NOTCH3 |
notch receptor 3 [Source:HGNC Symbol;Ac... |
206291_at |
4922 |
NTS |
neurotensin [Source:HGNC Symbol;Acc:HGN... |
208025_s_at |
8091 |
HMGA2 |
high mobility group AT-hook 2 [Source:H... |
215933_s_at |
3087 |
HHEX |
hematopoietically expressed homeobox [S... |
221526_x_at |
56288 |
PARD3 |
par-3 family cell polarity regulator [S... |
228038_at |
6657 |
SOX2 |
SRY-box transcription factor 2 [Source:... |
229768_at |
143503 |
OR51E1 |
olfactory receptor family 51 subfamily ... |
|
Version history |
|